|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4 Pt 1
|
|
pubmed:dateCreated |
1992-9-17
|
|
pubmed:abstractText |
We report a case involving orthotopic heart transplantation in which a recipient, known to be serologically negative for hepatitis B virus infection, received a heart from a donor known before transplantation to be hepatitis B surface antigen positive. The recipient was treated prospectively with a combination of hepatitis B immune globulin and hepatitis B vaccine. After 10 months of follow-up, the recipient has not experienced seroconversion or viremia from hepatitis B virus and has remained without symptoms by both clinical and laboratory measurements.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1053-2498
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
11
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
781-3
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:1386752-Heart Transplantation,
pubmed-meshheading:1386752-Hepatitis B,
pubmed-meshheading:1386752-Hepatitis B Surface Antigens,
pubmed-meshheading:1386752-Hepatitis B Vaccines,
pubmed-meshheading:1386752-Humans,
pubmed-meshheading:1386752-Immunization, Passive,
pubmed-meshheading:1386752-Immunoglobulins,
pubmed-meshheading:1386752-Male,
pubmed-meshheading:1386752-Middle Aged,
pubmed-meshheading:1386752-Vaccination,
pubmed-meshheading:1386752-Vaccines, Synthetic,
pubmed-meshheading:1386752-Viral Hepatitis Vaccines
|
|
pubmed:articleTitle |
A successful regimen for the prevention of seroconversion after transplantation of a heart positive for hepatitis B surface antigen.
|
|
pubmed:affiliation |
Division of Infectious Disease, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298-0049.
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
